Biotech | December 22, 2021
Piramal Pharma takes a minority stake in Yapan Bio
The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space
The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space
The setting up of these 8 plants will lead to a total committed investment of Rs. 260.40 crore
MJ will be paid a one-time lumpsum licence fee of Rs 15 crore
The funds will be used to scale up existing operations and launch new products
Share of government health expenditure in total health expenditure increases to 40.8% (2017-18) from 28.6% (2013-14)
_256_384.jpg)
India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution
For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore
J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021
The Board of Directors of Wockhardt have approved the unaudited consolidated financial results for the period ended September 30, 2021.
The Board of Directors of Aurobindo Pharma have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
Subscribe To Our Newsletter & Stay Updated
